Antoxerene and Juvenescence launch FoxBio to develop anti-aging drugs

Antoxerene, a pharmaceutical company dedicated to developing senolytic drugs, has partnered with investment firm Juvenescence to form a joint venture named FoxBio. This new entity ... Read More